CCG-2046

• Description :

  CCG-2046 is a RGS4 inhibitor with an IC50 of 4.3 μM against RGS4-Gαo interaction signal[1].

• UNSPSC :

  12352211

• Hazard Statement :

  H301-H311-H315-H319-H331-H335

• Target :

  RGS Protein

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/ccg-2046.html

• Solubility :

  10 mM in DMSO

• Smiles :

  N#CC1(C(C#N)(C#N)C1(C)CCC)C#N

• Molecular Formula :

  C11H10N4

• Molecular Weight :

  198.22

• Precautions :

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P361+P364-P362+P364-P403+P233-P405-P501

• References & Citations :

  [1]Roman DL, et al. Identification of small-molecule inhibitors of RGS4 using a high-throughput flow cytometry protein interaction assay. Mol Pharmacol. 2007 Jan;71 (1) :169-75.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  RGS4

• CAS Number :

  [13017-69-1]